September 12, 2019 10:25 AM EDT
News Briefing

Bay­er trims 2 top ex­ecs, shrinks man­age­ment board; Spring­Works boosts size of IPO

Kathy Wong

Editor

→ Af­ter wel­com­ing J&J deal­mak­er Mar­i­anne De Backer to their team as BD chief a lit­tle more than a week ago, Bay­er

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Bio­gen brings in med­ical chief as CFO plans re­tire­ment; Macro­Gen­ics CEO an­nounces de­par­ture

No­vo Nordisk claims late-stage MASH vic­to­ry, con­tin­u­ing GLP-1's ex­pan­sion

Es­sa’s shares tank as it looks for op­tions af­ter aban­don­ing prostate can­cer drug

UCB's an­ti-tau Alzheimer's pro­gram fails Phase 2 pri­ma­ry end­point, but high­lights pos­i­tive sec­on­daries

Q&A with Obe­si­ty So­ci­ety’s CEO as the field pre­pares for next-gen meds

Ex­clu­sive: Blood stem cell ther­a­py mak­er Garu­da gets new CEO, adds $47M

A service from the Financial Times